Medicare Enrolled

Dr. Praneetha Musty, MBBS/MD

Rheumatology · Smyrna, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
4441 ATLANTA RD SE STE 315, Smyrna, GA 30080
7703332035
Registered in NPPES since 2012
NPI: 1306191820 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Musty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Musty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Musty

Dr. Praneetha Musty is a rheumatology specialist in Smyrna, GA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Musty performed 1,148 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Musty received a total of $10,883 from 40 pharmaceutical and/or device companies across 682 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Musty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ 1,148 Medicare services $10,883 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,148
Medicare services
Bottom 40% in GA for rheumatology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
118 $72 $167
Autoimmune disorder antibody test
A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders.
112 $18 $40
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
92 $8 $9
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
91 $10 $55
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
89 $8 $25
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
83 $6 $20
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
81 $5 $20
Erythrocyte sedimentation rate (ESR) test
A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine.
79 $4 $20
Complement and antigen measurement
A laboratory test to measure levels of complement proteins and antigens in the blood.
76 $12 $80
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
45 $4 $20
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
39 $106 $319
DNA antibody test (native or double-stranded)
A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body.
38 $13 $75
Rheumatoid factor level 32 $6 $30
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
31 $29 $90
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
31 $40 $130
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
26 $11 $40
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
22 $27 $90
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
21 $2 $15
Rheumatoid arthritis antibody test
A blood test to measure antibodies used in assessing rheumatoid arthritis.
16 $13 $40
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
15 $3 $15
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
11 $34 $202
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,883
Total received (2018-2024)
Avg $1,555/year across 7 years
Top 33% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
682
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$695
2023
$1,534
2022
$3,298
2021
$2,351
2020
$1,024
2019
$1,885
2018
$97

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$133
UCB, Inc.
$77
E.R. Squibb & Sons, L.L.C.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
ABBVIE INC.
$65
Genentech USA, Inc.
$49
AstraZeneca Pharmaceuticals LP
$44
Amgen Inc.
$41
GlaxoSmithKline, LLC.
$34
Mallinckrodt Hospital Products Inc.
$28
Janssen Biotech, Inc.
$28
Aurinia Pharma U.S., Inc.
$24
Actelion Pharmaceuticals US, Inc.
$21
Organon Llc
$9
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,470
Novartis Pharmaceuticals Corporation
$1,017
PFIZER INC.
$994
Janssen Biotech, Inc.
$747
ABBVIE INC.
$696
UCB, Inc.
$601
GlaxoSmithKline, LLC.
$578
Genentech USA, Inc.
$559
Lilly USA, LLC
$512
Horizon Therapeutics plc
$352
Cumberland Pharmaceuticals, Inc.
$333
AbbVie Inc.
$316
E.R. Squibb & Sons, L.L.C.
$302
AbbVie, Inc.
$205
AstraZeneca Pharmaceuticals LP
$149
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Regeneron Healthcare Solutions, Inc.
$134
Horizon Pharma plc
$97
Mallinckrodt Enterprises LLC
$94
Mallinckrodt Hospital Products Inc.
$87
Abbott Laboratories
$66
Aurinia Pharma U.S., Inc.
$59
SANOFI-AVENTIS U.S. LLC
$53
Novo Nordisk Inc
$49
GENZYME CORPORATION
$29
Celgene Corporation
$24
Actelion Pharmaceuticals US, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Sandoz Inc.
$19
GRT US Holding, Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$15
Radius Health, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$14
Eisai Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
Exeltis, USA Inc.
$13
Hikma Pharmaceuticals USA
$13
Corcept Therapeutics
$13
Organon Llc
$9
Top 3 companies account for 41.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BAQSIMI · BENLYSTA · Bimzelx · COLOGUARD · COSENTYX · Cimzia · Crysvita · Dayvigo · EMGALITY · EVENITY · EVUSHELD · Enbrel · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE PFS · HUMIRA · HYRIMOZ · Humira · INFLECTRA · JARDIANCE · KEVZARA · KRISTALOSE · KRYSTEXXA · Kerendia · Korlym · LUPKYNIS · LYRICA · LYUMJEV · Mitigare · OFEV · OPSUMIT · ORENCIA · Otezla · Ozempic · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · RYBELSUS · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Truxima · Tymlos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Smyrna?
Compare rheumatologists in the Smyrna area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
75
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
RIDGEVIEW INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Musty is a mixed practice specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Musty experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Musty performed 118 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Musty receive payments from pharmaceutical companies?
Yes. Dr. Musty received a total of $10,883 from 40 companies across 682 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Musty's costs compare to other rheumatologists in Smyrna?
Dr. Musty's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Musty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →